Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

CEFTRIAXONE INJECTI

Awarded
SPE2DP26F8784Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Defense Logistics Agency award SPE2DP26F8784 is a delivery order issued under base contract SPE2DX25D9900 to DMS Pharmaceutical Group Inc for the procurement of Ceftriaxone Injectable. The contract, awarded on August 5, 2026, is valued at 90.38 dollars for the delivery of two packages at a unit price of 45.19 dollars. This acquisition falls under NAICS code 325412 and is designated for a small business, with eligibility noted for HubZone, Service-Disabled Veteran-Owned, and Women-Owned Small Business programs. The items are to be delivered FOB Destination to Fort Bragg, North Carolina, by August 20, 2026. Shipping must be conducted via traceable means, excluding parcel post, and must include specific marking instructions such as the full shipping address and NDC number. Inspection and acceptance are the responsibility of the government upon delivery at the destination. Administrative oversight is managed by DLA Troop Support Medical Supply Chain in Philadelphia, with payments processed through the Defense Finance and Accounting Service in Columbus, Ohio. The contract incorporates standard commercial item terms and conditions per FAR 52.212-4 and 52.212-5, as well as FAR 52.222-50 regarding combating trafficking in persons.

General Info

DLA awarded DMS Pharmaceutical Group 90.38 dollars for Ceftriaxone Injectable delivered to Fort Bragg.

Contract Value

$90.38

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

2

SPE2DP-26-F-8784 - Ceftriaxone Injectable Award

PDF, High priority: read this firstaward
High

SPE2DX-25-D-9900 - DMS Pharmaceutical Group Inc

PDF, High priority: read this firstaward
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F8784 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $90.38 Award Date: 08-05-2026 Delivery order under: SPE2DX25D9900 Line items: - CEFTRIAXONE INJECTI (NSN/Part 6505015544282, PR 7017770659)

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS